ReviewCurrent psychiatry reports2014
Schizotypal personality disorder: a current review.
Review in Current psychiatry reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04764708 (Compassion and Metacognition Based Therapy for Schizotypal Personality Disorder), which is not on this map. Cited by 53 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Compassion and Metacognition Based Therapy for Schizotypal Personality Disorder: A Pilot Non-inferiority Randomized Controlled Trial on Repeated Measures.
Who cites it
53 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Cortical and subcortical neuroanatomical signatures of schizotypy in 3004 individuals assessed in a worldwide ENIGMA study.Molecular psychiatry · 2022Pooled it
- Trial
- Neurophysiological evidence of impaired self-monitoring in schizotypal personality disorder and its reversal by dopaminergic antagonism.NeuroImage. Clinical · 2016Trial
- Aberrant effective connectivity during working memory performance in schizotypal personality disorder and schizophrenia: A spectrum approach.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026Article
- Psychometric properties of the schizotypal personality questionnaire-brief revised (SPQ-BR) in a German-speaking sample.Scientific reports · 2026Article
- The unique contribution of Schizotypal personality subscales to psychotic-like experiences and social-personality factors in Hong Kong community youths.Frontiers in psychiatry · 2026Article
- Modelling the longitudinal associations between schizotypy and aberrant salience: The role of mentalization and attachment.Psychology and psychotherapy · 2025Article
- Neuro- and social-cognition in schizotypal personality disorder and schizophrenia: A spectrum of severity.Psychiatry research · 2025Article
- Association between psychological distress and schizotypy in adults: A cross-sectional study.Neuropsychopharmacology reports · 2025Article
- Differences in Real-world Functioning Between Adoptees With High or Low Risk for Schizophrenia Spectrum Disorders-The Finnish Adoptive Family Study of Schizophrenia.Schizophrenia bulletin open · 2025Article
- The Effect of Neuropsychiatric Drugs on the Oxidation-Reduction Balance in Therapy.International journal of molecular sciences · 2024Review
- The genetic epidemiology of schizotypal personality disorder.Psychological medicine · 2024Article
- The Complexity of Borderline Personality Disorder: Network Analysis of Personality Factors and Defense Styles in the Context of Borderline Personality Organization.Psychiatry investigation · 2024Article
- The MATRICS consensus cognitive battery for the assessment of cognitive impairment in schizotypal personality disorder.Schizophrenia research · 2024Article
- Metacognition as a Transdiagnostic Determinant of Recovery in Schizotypy and Schizophrenia Spectrum Disorders.Behavioral sciences (Basel, Switzerland) · 2024Review
- The Translational Future of Stress Neurobiology and Psychosis Vulnerability: A Review of the Evidence.Current neuropharmacology · 2024Review
- The relationship between script memory for everyday events and schizotypy: an investigation through a development of Japanese Situational Feature Recognition Test.Frontiers in psychiatry · 2024Article
- Phenomenological and Cognitive Features Associated With Auditory Hallucinations in Clinical and Nonclinical Voice Hearers.Schizophrenia bulletin · 2023Article
- Treatment of schizotypal disorder: a protocol for a systematic review of the evidence and recommendations for clinical practice.BMJ open · 2023Article
- Characterizing sustained social anxiety in individuals at clinical high risk for psychosis: trajectory, risk factors, and functional outcomes.Psychological medicine · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The study of schizotypal personality disorder (SPD) is important clinically, as it is understudied, challenging to treat, often under-recognized or misdiagnosed, and associated with significant functional impairment. SPD also represents an intermediate schizophrenia-spectrum phenotype, and therefore, can provide a better understanding of the genetics, pathogenesis, and treatment of related psychotic illnesses. In this review we discuss recent findings of SPD related to epidemiology and functional impairment, heritability and genetics, working memory and cognitive impairments, social-affective disturbances, and neurobiology. Additionally, we examine the challenges associated with treating patients with SPD, as well as clinical recommendations. Finally, we address future directions and areas in need of further exploration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.